Outcome for Advanced or Metastatic Soft Tissue Sarcoma of Nonextremities Treated with Doxorubicin-Based Chemotherapy: A Retrospective Study from a Single Cancer Institution.

Shoko MarshallKenji NakanoYoshiya SugiuraShinichiro TairaMakiko OnoJunichi TomomatsuShunji Takahashi

Published in: Sarcoma (2018)

Combination therapy showed better response and TTF than monotherapy but did not show better OS. Possible prognostic factors for OS were indicated. This retrospective study was approved by the institutional review board. This trial is registered with UMIN000028787.

Keyphrases

combination therapy
prognostic factors
papillary thyroid
squamous cell carcinoma
small cell lung cancer
study protocol
squamous cell
phase iii
clinical trial
drug delivery
locally advanced
phase ii
cancer therapy
randomized controlled trial
open label
childhood cancer
newly diagnosed
young adults
rectal cancer